Patents by Inventor Kyu Won Cho

Kyu Won Cho has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240125706
    Abstract: A surface plasmon resonance imaging apparatus is provided. The surface plasmon resonance imaging apparatus includes a light irradiation unit configured to irradiate polarized light onto a metal coating film provided on one surface of a prism, a light modulator configured to spatially pattern-encode light reflected by the metal coating film and the prism, a light detector configured to detect a pattern-encoded light signal, obtained through pattern-encoding by the light modulator, as a spectral signal, a signal processor configured to spatially decode the spectral signal and analyze a decoded spectral signal to generate characteristic data of a sample provided on the metal coating film, and an output unit configured to output the characteristic data of the sample as a two-dimensional (2D) image.
    Type: Application
    Filed: December 29, 2022
    Publication date: April 18, 2024
    Applicant: Electronics and Telecommunications Research Institute
    Inventors: SOOCHEOL KIM, JeongKyun KIM, Hyunseok KIM, Jin Hwa RYU, SO YUNG PARK, Hoe-Sung YANG, KANG BOK LEE, Sun-Hwa LIM, Kwang-Soo CHO, Kyu Won HAN, Sang Gi HONG
  • Patent number: 11945744
    Abstract: Disclosed are a method and apparatus for reusing wastewater. The method for reusing wastewater disclosed herein includes: generating a mixed wastewater by mixing multiple types of wastewater (S20); performing a first purification by passing the mixed wastewater through a flocculation-sedimentation unit (S40); performing a second purification by passing an effluent of the flocculation-sedimentation unit through a membrane bioreactor (MBR) (S60); performing a third purification by passing an effluent of the MBR through a reverse-osmosis membrane unit (S80); and reusing an effluent of the reverse-osmosis membrane unit as cooling water or industrial water (S100).
    Type: Grant
    Filed: April 14, 2023
    Date of Patent: April 2, 2024
    Assignees: SAMSUNG ENGINEERING CO., LTD., SAMSUNG ELECTRONICS CO., LTD
    Inventors: Seok Hwan Hong, Dae Soo Park, Seung Joon Chung, Yong Xun Jin, Jae Hyung Park, Jae Hoon Choi, Jae Dong Hwang, Jong Keun Yi, Su Hyoung Cho, Kyu Won Hwang, June Yurl Hur, Je Hun Kim, Ji Won Chun
  • Publication number: 20240083351
    Abstract: A lighting device includes a light guide plate configured to guide and diffuse a light from a light source, and a garnish body including a lighting area to which the diffused light is radiated, wherein the light guide plate is disposed at a predetermined angle with respect to the garnish body.
    Type: Application
    Filed: September 5, 2023
    Publication date: March 14, 2024
    Inventors: Jun Geun Oh, Min Ha Lee, Kyu Rok Kim, Byoung Wook Kim, Hoe Won Jung, Ho Sung Shin, Seong Cheon Cho
  • Publication number: 20240077417
    Abstract: The disclosure relates to a non-dispersive infrared (NDIR) gas sensor which detects the concentration of gas with a simple structure and method by manufacturing an optical waveguide with a gas-permeable polymer material instead of a conventional cavity or chamber type. An optical signal travels through the optical waveguide of gas-permeable polymer by total internal reflection, and the gas naturally penetrates the optical waveguide without the use of separate inlet and outlet openings, so that the optical signal and gas particles come into contact with each other within the optical waveguide. Since the optical signal detected by a photodetector at the other end of the optical waveguide after traveling while contacting the gas particles has properties changed according to the concentration of the gas which they have contacted in the optical waveguide, it is possible to measure the concentration of a specific gas from the detected optical signal.
    Type: Application
    Filed: July 11, 2023
    Publication date: March 7, 2024
    Applicant: ELECTRONICS AND TELECOMMUNICATIONS RESEARCH INSTITUTE
    Inventors: Jin Hwa RYU, Soocheol KIM, Hyunseok KIM, So Yung PARK, Hoe-Sung YANG, Kang Bok LEE, Kwang-Soo CHO, Kyu Won HAN
  • Patent number: 10524329
    Abstract: A pulse width modulation (PWM) signal generator according to one embodiment of the present invention includes a first comparison unit for comparing a duty value being inputted with a reference wave being inputted to output a first PWM signal, a signal inversion unit for inverting the duty value being inputted on the basis of a maximum value of the reference wave, a second comparison unit for comparing the duty value inverted by the signal inversion unit with the reference wave being inputted to output a second PWM signal, and a reference wave generator for generating a reference wave to transmit the same to each of the first comparison unit and the second comparison unit.
    Type: Grant
    Filed: December 22, 2017
    Date of Patent: December 31, 2019
    Assignee: FEELUX CO., LTD.
    Inventor: Kyu Won Cho
  • Publication number: 20190350064
    Abstract: A pulse width modulation (PWM) signal generator according to one embodiment of the present invention includes a first comparison unit for comparing a duty value being inputted with a reference wave being inputted to output a first PWM signal, a signal inversion unit for inverting the duty value being inputted on the basis of a maximum value of the reference wave, a second comparison unit for comparing the duty value inverted by the signal inversion unit with the reference wave being inputted to output a second PWM signal, and a reference wave generator for generating a reference wave to transmit the same to each of the first comparison unit and the second comparison unit.
    Type: Application
    Filed: December 22, 2017
    Publication date: November 14, 2019
    Inventor: Kyu Won CHO
  • Patent number: 9631020
    Abstract: Disclosed are a human antibody comprising a human complementarity-determining region (CDR), which binds specifically to c-Met, and a framework region (FR), a polynucleotide encoding the human antibody, an expression vector comprising the polynucleotide, a transformant transformed with the expression vector, a method of producing the human antibody B7 by culturing the transformant, a wound healing composition comprising the human antibody as an active ingredient, a cell regeneration composition comprising the antibody as an active ingredient, and a drug conjugate comprising a drug linked to the human antibody. The c-Met-specific human antibody can function as an HGF mimic that can be used as a wound healing composition. The antibody can be widely used to determine the treatment and prognosis of various diseases, including neuronal infarction, progressive nephropathy, liver cirrhosis, lung fibrosis, kidney injury, liver injury, lung injury, and ulcerative wounds, which are treated by activation of HGF or c-Met.
    Type: Grant
    Filed: June 4, 2012
    Date of Patent: April 25, 2017
    Assignees: Korea Research Institute of Bioscience and Biotechnology, Y-Biologics Inc.
    Inventors: Young Woo Park, Ki Won Jo, Chan Woong Park, Seok Ho Yoo, Myeoung Hee Jang, Hye Nan Kim, Seon Ha Yun, Kyu Won Cho, Mi Ra Park
  • Patent number: 9617304
    Abstract: The present invention relates to a novel endocytic motif, and in particular, to a fusion polypeptide including the motif represented by an amino acid sequence of SEQ ID NO. 1 and a protein transduction domain, a pharmaceutical composition for preventing or treating cancer including the same, and a method for treating cancer including the step of administering the composition. The present invention shows the effects of suppressing metastasis, infiltration, angiogenesis, and growth of cancer by specifically inhibiting c-Met endocytosis and effectively inhibiting HGF/c-Met signaling pathway associated with metastasis and growth of various types of cancer cells. Therefore, the present invention can be applied to an anticancer agent for various types of cancer.
    Type: Grant
    Filed: March 2, 2012
    Date of Patent: April 11, 2017
    Assignee: Korea Research Institute Of Bioscience And Biotechnology
    Inventors: Young Woo Park, Ki Won Jo, Kyu Won Cho, Ji Hyun Park, Soon Sil Hyun, Yun Jung Park
  • Patent number: 8962180
    Abstract: A rechargeable battery including an electrode assembly; a case in which the electrode assembly is installed; a cap assembly coupled to an opening of the case and to an externally protruded terminal, the cap assembly including a cap plate; a first gasket between the terminal and the cap plate; and a second gasket between the terminal and the cap plate, the second gasket having a blocking portion overlapped with the first gasket.
    Type: Grant
    Filed: November 23, 2010
    Date of Patent: February 24, 2015
    Assignees: Samsung SDI Co., Ltd., Robert Bosch GmbH
    Inventors: Sang-Won Byun, Sung-Bae Kim, Kyu-Won Cho
  • Patent number: 8916525
    Abstract: The present invention relates to TNFR2-TWEAKR fusion protein, more precisely to TNFR2-TWEAKR fusion protein acting as a double-antagonist to TNF-? and TWEAK, known as major causes of autoimmune arthritis which is one of autoimmune diseases. When the composition comprising TNFR2-TWEAKR fusion protein was treated to Th17 cells, the secretion of the inflammatory cytokine IL-17 was reduced but the secretion of the anti-inflammatory cytokine IL-10 generated in Treg cells was increased. Such effect of TNFR2-TWEAKR fusion protein was far greater than that of a single protein such as TNFR2-Fc or TWEAK-Fc. The TNFR2-TWEAKR fusion protein of the present invention has not only excellent treatment effect on arthritis in CIA mouse model not also excellent treatment effect on autoimmune rheumatoid arthritis by increasing the expression of Treg, the immune suppressive cells.
    Type: Grant
    Filed: March 18, 2011
    Date of Patent: December 23, 2014
    Assignees: Korea Research Institute of Bioscience and Biotechnology, Industry-Academic Cooperation Foundation, The Catholic University of Korea
    Inventors: Young Woo Park, Ki Won Jo, Srok Ho Yoo, Jung Yu, Dong Jin Kim, Sun-Ha Yoon, Eun Jung Song, Eun Kyung Lee, Jin Mi Oh, Kyu Won Cho, Mi La Cho, Ho Youn Kim, Mi Kyung Park, Hye Jwa Oh, Jin Sil Park, Yun Ju Woo, Jae Kyeong Byun, Jun Geol Ryu
  • Publication number: 20140193431
    Abstract: Disclosed are a human antibody comprising a human complementarity-determining region (CDR), which binds specifically to c-Met, and a framework region (FR), a polynucleotide encoding the human antibody, an expression vector comprising the polynucleotide, a transformant transformed with the expression vector, a method of producing the human antibody B7 by culturing the transformant, a wound healing composition comprising the human antibody as an active ingredient, a cell regeneration composition comprising the antibody as an active ingredient, and a drug conjugate comprising a drug linked to the human antibody. The c-Met-specific human antibody can function as an HGF mimic that can be used as a wound healing composition. The antibody can be widely used to determine the treatment and prognosis of various diseases, including neuronal infarction, progressive nephropathy, liver cirrhosis, lung fibrosis, kidney injury, liver injury, lung injury, and ulcerative wounds, which are treated by activation of HGF or c-Met.
    Type: Application
    Filed: June 4, 2012
    Publication date: July 10, 2014
    Applicant: Korea Research Institute of Bioscience and Biotechnology
    Inventors: Young Woo Park, KiWon Jo, Chan Woong Park, Seok Ho Yoo, Myeoung Hee Jang, Hye Nan Kim, Seon Ha Yun, Kyu Won Cho, Mi Ra Park
  • Publication number: 20140066375
    Abstract: The present invention relates to a novel endocytic motif, and in particular, to a fusion polypeptide including the motif represented by an amino acid sequence of SEQ ID NO. 1 and a protein transduction domain, a pharmaceutical composition for preventing or treating cancer including the same, and a method for treating cancer including the step of administering the composition. The present invention shows the effects of suppressing metastasis, infiltration, angiogenesis, and growth of cancer by specifically inhibiting c-Met endocytosis and effectively inhibiting HGF/c-Met signaling pathway associated with metastasis and growth of various types of cancer cells. Therefore, the present invention can be applied to an anticancer agent for various types of cancer.
    Type: Application
    Filed: March 2, 2012
    Publication date: March 6, 2014
    Inventors: Young Woo Park, Ki Won Jo, Kyu Won Cho, Ji Hyun Park, Soon Sil Hyun, Yun Jung Park
  • Publication number: 20130017226
    Abstract: The present invention relates to TNFR2-TWEAKR fusion protein, more precisely to TNFR2-TWEAKR fusion protein acting as a double-antagonist to TNF-? and TWEAK, known as major causes of autoimmune arthritis which is one of autoimmune diseases. When the composition comprising TNFR2-TWEAKR fusion protein was treated to Th17 cells, the secretion of the inflammatory cytokine IL-17 was reduced but the secretion of the anti-inflammatory cytokine IL-10 generated in Treg cells was increased. Such effect of TNFR2-TWEAKR fusion protein was far greater than that of a single protein such as TNFR2-Fc or TWEAK-Fc. The TNFR2-TWEAKR fusion protein of the present invention has not only excellent treatment effect on arthritis in CIA mouse model not also excellent treatment effect on autoimmune rheumatoid arthritis by increasing the expression of Treg, the immune suppressive cells.
    Type: Application
    Filed: March 18, 2011
    Publication date: January 17, 2013
    Applicants: Industry-Academic Cooperation Foundation, The Catholic University of Korea, Korea Research Institute of Bioscience and Biotechnology
    Inventors: Young Woo Park, Ki Won Jo, Srok Ho Yoo, Jung Yu, Dong Ji Kim, Sun-Ha Yoon, Eun Jung Song, Eun Kyung Lee, Jin Mi Oh, Kyu Won Cho, Mi La Cho, Ho Youn Kim, Mi Kyung Park, Hye Jwa Oh, Jin Sil Park, Yun Ju Woo, Jae Kyeong Byun, Jun Geol Ryu
  • Publication number: 20110287310
    Abstract: A rechargeable battery including an electrode assembly; a case in which the electrode assembly is installed; a cap assembly coupled to an opening of the case and to an externally protruded terminal, the cap assembly including a cap plate; a first gasket between the terminal and the cap plate; and a second gasket between the terminal and the cap plate, the second gasket having a blocking portion overlapped with the first gasket.
    Type: Application
    Filed: November 23, 2010
    Publication date: November 24, 2011
    Inventors: Sang-Won Byun, Sung-Bae Kim, Kyu-Won Cho
  • Publication number: 20110136003
    Abstract: A rechargeable battery includes a case; an electrode assembly housed in the case and having a first substantially planar surface, a second substantially planar surface and a connecting portion connecting the substantially planar surfaces; and a support plate between the case and the electrode assembly, wherein the support plate is electrically coupled to the electrode assembly and has a substantially planar portion generally adjacent to and overlapping at least one of the substantially planar surfaces.
    Type: Application
    Filed: December 2, 2010
    Publication date: June 9, 2011
    Inventors: Yong-Sam Kim, Kyu-Won Cho, Soo-Kyoung Yoo
  • Publication number: 20050156014
    Abstract: Disclosed are a structure of multi-layered clad plates and sheets for corrosion resistance and a fabricating method thereof. Provided are clad plates and sheets for corrosion resistance in which Ni, Co, Ti, Ni, V, and Zr having an excellent corrosion resistance, or an alloy thereof are bonded to cheap Fe, Cu, or an alloy thereof. Chemical compositions of the clad metals and structures of the clad plates and sheets are easily modified with service conditions of the clad plates and sheets. Also, this invention provides a more cost-effective method based on a. resistance seam welding process for fabricating the corrosion-resistant clad plates and sheets.
    Type: Application
    Filed: December 16, 2004
    Publication date: July 21, 2005
    Applicant: Korea Institute of Science and Technology
    Inventors: Jung Mann Doh, Ji Young Byun, Kyu Won Cho, Ju Yong Jung
  • Patent number: 6835467
    Abstract: Disclosed are a structure of multi-layered clad plates and sheets for corrosion resistance and a fabricating method thereof. Provided are clad plates and sheets for corrosion resistance in which Ni, Co, Ti, Nb, V, and Zr having an excellent corrosion resistance, or an alloy thereof are bonded to cheap Fe, Cu, or an alloy thereof. Chemical compositions of the clad metals and structures of the clad plates and sheets are easily modified with service conditions of the clad plates and sheets. Also, this invention provides a more cost-effective method based on a resistance seam welding process for fabricating the corrosion-resistant clad plates and sheets.
    Type: Grant
    Filed: January 16, 2003
    Date of Patent: December 28, 2004
    Assignee: Korea Institute of Science and Technology
    Inventors: Jung Mann Doh, Ji Young Byun, Kyu Won Cho, Ju Yong Jung
  • Publication number: 20040048096
    Abstract: Disclosed are a structure of multi-layered clad plates and sheets for corrosion resistance and a fabricating method thereof. Provided are clad plates and sheets for corrosion resistance in which Ni, Co, Ti, Ni, V, and Zr having an excellent corrosion resistance, or an alloy thereof are bonded to cheap Fe, Cu, or an alloy thereof: Chemical compositions of the clad metals and structures of the clad plates and sheets are easily modified with service conditions of the clad plates and sheets. Also, this invention provides a more cost-effective method based on a resistance seam welding process for fabricating the corrosion-resistant clad plates and sheets.
    Type: Application
    Filed: January 16, 2003
    Publication date: March 11, 2004
    Applicant: Korea Institute of Science and Technology
    Inventors: Jung Mann Doh, Ji Young Byun, Kyu Won Cho, Ju Yong Jung